Kaune R, Schroeder B, Harmeyer J
Department of Physiology, School of Veterinary Medicine, Hannover, FRG.
Arch Biochem Biophys. 1990 Nov 1;282(2):326-32. doi: 10.1016/0003-9861(90)90124-h.
The effective treatment of the rachitic symptoms of pseudo-vitamin D-deficiency rickets, type I (PVDRI) by massive doses of vitamin D3 was examined. For this purpose, the affinities and the maximum binding capacities (Bmax) of the plasma vitamin D-binding protein (DBP) and of the intestinal 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) receptor for vitamin D3, 25-hydroxyvitamin D3 (25-OHD3) and 1,25-(OH)2D3, were investigated in normal piglets and in rachitic piglets that suffered from PVDRI. The piglets were 5 to 10 weeks old and of both sexes. The Bmax of plasma DBP for 25-OHD3 was 6.77 +/- 0.45 microM for PVDRI piglets and 7.30 +/- 0.41 microM for control piglets and showed no differences between the two groups. Equilibrium association constants (Ka) of DBP for 25-OHD3 were 4.3 x 10(8) M-1 for PVDRI piglets and 4.0 x 10(8) M-1 for controls and showed also no differences between the two groups. Similarly the Ka of DBP for 1,25-(OH)2D3 was also the same for rachitic and control piglets (1.45 x 10(7) and 1.54 x 10(7) M-1, respectively). Due to the lower circulating concentration of 1,25-(OH)2D3 in the plasma of rachitic piglets compared to that of controls its free metabolite index was significantly lower in rachitic (0.42 +/- 0.05 x 10(-5)) than in control piglets (3.63 +/- 0.30 x 10(-5)). The Kd and Bmax of the intestinal nuclear receptor for 1,25-(OH)2D3 of rachitic and control piglets were 0.31 +/- 0.05 and 0.33 +/- 0.05 nM and 674 +/- 103 and 719 +/- 123 fmol/mg protein, respectively, and were also not different between the two groups of piglets. It was concluded from these observations that the rachitic symptoms of PVDRI piglets resulted solely from the lower free 1,25-(OH)2D3 concentration in plasma compared to that of normal piglets. The relative affinities of the intestinal 1,25-(OH)2D3 receptor for vitamin D3 and 25-OHD3 were also measured. It was found that 50% displacement of 1,25-(OH)2D3 from the intestinal receptor of PVDRI and control piglets required a 220,000- and 245,000-fold excess of the free concentration of vitamin D3, respectively, and a 20- to 42- and 23- to 71-fold excess of the free concentration of 25-OHD3, respectively.(ABSTRACT TRUNCATED AT 400 WORDS)
研究了大剂量维生素D3对I型假性维生素D缺乏性佝偻病(PVDRI)佝偻病症状的有效治疗作用。为此,在正常仔猪和患有PVDRI的佝偻病仔猪中,研究了血浆维生素D结合蛋白(DBP)和肠道1,25-二羟基维生素D3(1,25-(OH)2D3)受体对维生素D3、25-羟基维生素D3(25-OHD3)和1,25-(OH)2D3的亲和力及最大结合容量(Bmax)。仔猪年龄为5至10周,雌雄均有。PVDRI仔猪血浆DBP对25-OHD3的Bmax为6.77±0.45μM,对照仔猪为7.30±0.41μM,两组之间无差异。PVDRI仔猪DBP对25-OHD3的平衡缔合常数(Ka)为4.3×10⁸M⁻¹,对照仔猪为4.0×10⁸M⁻¹,两组之间也无差异。同样,佝偻病仔猪和对照仔猪DBP对1,25-(OH)2D3的Ka也相同(分别为1.45×10⁷和1.54×10⁷M⁻¹)。由于佝偻病仔猪血浆中1,25-(OH)2D3的循环浓度低于对照仔猪,其游离代谢物指数在佝偻病仔猪中(0.42±0.05×10⁻⁵)显著低于对照仔猪(3.63±0.30×10⁻⁵)。佝偻病仔猪和对照仔猪肠道核受体对1,25-(OH)2D3的解离常数(Kd)和Bmax分别为0.31±0.05和0.33±0. .05 nM以及674±103和719±123 fmol/mg蛋白,两组仔猪之间也无差异。从这些观察结果得出结论,PVDRI仔猪的佝偻病症状完全是由于血浆中游离1,25-(OH)2D3浓度低于正常仔猪。还测量了肠道1,25-(OH)2D3受体对维生素D3和25-OHD3的相对亲和力。发现从PVDRI和对照仔猪的肠道受体中置换50%的1,25-(OH)2D3,分别需要游离维生素D3浓度过量220,000倍和245,000倍,以及游离25-OHD3浓度过量20至42倍和23至71倍。(摘要截断于400字)